Effect of Triguna Makaradhwaja and Shadguna Makaradhwaja in Diabetes Mellitus.

Role of Gandhaka Jarana in the preparation of Makaradhwaja - MAK

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2016/09/007267

Enrollment

Registered

2016-09-09

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients suffering from Type 2 Diabetes Mellitus without any complicatins like neuropathy, nephropathy and retinopathy.

Interventions

Intervention1: Triguna Balijarita makaradhwaja(TBM): Triguna Balijarita Makaradhwaja 14.63 mg and Guduchi Ghana 235.73mg. in capsule bid form for 28 days Intervention2: Shadguna Balijarita Makaradhwaj

Eligibility

Inclusion criteria

Inclusion criteria: Patients having signs and symptoms of Madhumeha as described in Ayurvedic classic Charaka Samhita and patients having sign and symptoms of Type II Diabetes Mellitus will be selected for the present study.

Exclusion criteria

Exclusion criteria: Diabetes Mellitus Type I and patients havoing Secondary complications of Diabets Mellitus Type II

Design outcomes

Primary

Measure	Time frame
Improvement in selected signs and symptoms of diseasesTimepoint: Up to October 2011	—

Secondary

Measure	Time frame
Shadguna Balijarita makaradhwaja was found better than Triguna Balijarita makaradhwajaTimepoint: Up to October 2011	—

Countries

India

Contacts

Public ContactProf Pradeepkumar Prajapati

Institute of Post Graduate Teaching and Research in Ayurveda.

prajapati.pradeep1@gmail.com9978403323

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026